Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant carboplatin + paclitaxel after cisplatin chemoradiation for locally advanced cervical cancer
ACTRN12610000732088Phase 3Completed
- Sponsor
- The University of Sydney
- Start
- Apr 2014
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, open-label trial of cisplatin, carboplatin and paclitaxel in Cervical Cancer (CC) (2 arms), sponsored by The University of Sydney. Primary endpoint: Overall survival. Started Apr 2014; status: completed.
02
Drugs
cisplatincarboplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ACTRN12610000732088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000732088.